The US produces 90% of the new medicines in the world. The absence of price controls on drugs makes that possible, and the rest of the world benefits from the work done in our research labs.
It's not easy being a drug company. Most research hits dead ends; the government has endless hurdles, litigation can drive you into bankruptcy - and everybody wants the stuff for free.
The WSJ says that this bounty of new treatments will be eliminated by price controls.